The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Oncogene

• Publication date

  2001-01-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1204049PMID 11313948
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transforming Ability of MEN2A-RET Requires Activation of the Phosphatidylinositol 3-Kinase/AKT Signaling Pathway*

  2000cited by this paper
• Akt/protein kinase B promotes survival and hormone-independent proliferation of thyroid cells in the absence of dedifferentiating and transforming effects.

  2000cited by this paper
• Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival.

  2000cited by this paper
• Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor

  2000cited by this paper
• The Signaling Adapter FRS-2 Competes with Shc for Binding to the Nerve Growth Factor Receptor TrkA

  1999cited by this paper
• The surprisingly flexible PTB domain.

  1999cited by this paper
• Cellular survival: a play in three Akts.

  1999influential reference
• Insulin receptor substrate-1 enhances growth hormone-induced proliferation.

  1999cited by this paper
• Rho-dependent and -independent tyrosine phosphorylation of focal adhesion kinase, paxillin and p130Cas mediated by Ret kinase

  1999influential reference
• Enhanced phosphatidylinositol 3-kinase activity and high phosphorylation state of its downstream signalling molecules mediated by ret with the MEN 2B mutation.

  1999influential reference
• Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site.

  1999cited by this paper
• Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms.

  1999influential reference
• Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site

  1999cited by this paper
• GDNF family neurotrophic factor signaling: four masters, one servant?

  1999cited by this paper
• Ret-dependent and -independent Mechanisms of Glial Cell Line-derived Neurotrophic Factor Signaling in Neuronal Cells*

  1999cited by this paper
• The Role of Phosphoinositide 3-Kinase Lipid Products in Cell Function*

  1999cited by this paper
• Shc and Enigma Are Both Required for Mitogenic Signaling by Ret/ptc2

  1998influential reference
• Grb2 binding to the different isoforms of Ret tyrosine kinase

  1998influential reference
• Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.

  1998cited by this paper
• Protein Kinase B Activation and Lamellipodium Formation Are Independent Phosphoinositide 3-Kinase-Mediated Events Differentially Regulated by Endogenous Ras

  1998cited by this paper
• Akt activation by growth factors is a multiple-step process: the role of the PH domain

  1998cited by this paper
• Signaling through scaffold, anchoring, and adaptor proteins.

  1997cited by this paper
• Identification of Shc docking site on Ret tyrosine kinase

  1997influential reference
• Insulin Receptor Substrate (IRS)-1 and IRS-2 Are Tyrosine-phosphorylated and Associated with Phosphatidylinositol 3-Kinase in Response to Brain-derived Neurotrophic Factor in Cultured Cerebral Cortical Neurons*

  1997cited by this paper
• RET alternate splicing influences the interaction of activated RET with the SH2 and PTB domains of Shc, and the SH2 domain of Grb2

  1997cited by this paper
• YMXM motifs and signaling by an insulin receptor substrate 1 molecule without tyrosine phosphorylation sites

  1996cited by this paper
• RET mutations in human disease.

  1996influential reference
• Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells

  1996cited by this paper
• Direct Association between the Ret Receptor Tyrosine Kinase and the Src Homology 2-containing Adapter Protein Grb7 (*)

  1996influential reference
• The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma

  1996cited by this paper
• A Mutation at Tyrosine 1062 in MEN2A-Ret and MEN2B-Ret Impairs Their Transforming Activity and Association with Shc Adaptor Proteins*

  1996influential reference
• Structural basis for IL-4 receptor phosphopeptide recognition by thelRS-1 PTB domain

  1996cited by this paper
• Oncogenic RET Receptors Display Different Autophosphorylation Sites and Substrate Binding Specificities (*)

  1996cited by this paper
• Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

  1995cited by this paper
• Interleukin-9 Induces Tyrosine Phosphorylation of Insulin Receptor Substrate-1 via JAK Tyrosine Kinases (*)

  1995cited by this paper
• Constitutive phosphorylation of eps8 in tumor cell lines: relevance to malignant transformation

  1995cited by this paper
• Interferon-alpha engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3'-kinase.

  1995cited by this paper
• PTB Domains of IRS-1 and Shc Have Distinct but Overlapping Binding Specificities (*)

  1995cited by this paper
• The Ret Receptor Protein Tyrosine Kinase Associates with the SH2-containing Adapter Protein Grb10 (*)

  1995influential reference
• Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

  1995cited by this paper
• Tyrosine Phosphorylation of Insulin Receptor Substrate-1 in Vivo Depends upon the Presence of Its Pleckstrin Homology Region (*)

  1995cited by this paper
• Interleukins 2, 4, 7, and 15 Stimulate Tyrosine Phosphorylation of Insulin Receptor Substrates 1 and 2 in T Cells POTENTIAL ROLE OF JAK KINASES (*)

  1995cited by this paper
• Interferon-α Engages the Insulin Receptor Substrate-1 to Associate with the Phosphatidylinositol 3′-Kinase (*)

  1995cited by this paper
• An epidermal growth factor receptor/ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway

  1994cited by this paper
• SH2/SH3 signaling proteins.

  1994cited by this paper
• An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth.

  1994cited by this paper
• How receptor tyrosine kinases activate Ras.

  1993cited by this paper
• IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells.

  1993cited by this paper
• The function of GRB2 in linking the insulin receptor to Ras signaling pathways.

  1993cited by this paper
• A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction.

  1992cited by this paper

• Molecular pathogenesis and therapeutic advances in RET fusion-positive papillary thyroid carcinoma.

  2026cites this paper
• Hydroalcoholic Extracts of Cucumis prophetarum L. Affect the Insulin Signaling Pathway in an In Vitro Model of Insulin-Resistant L6 Myotubes

  2026cites this paper
• RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectives.

  2023cites this paper
• Serum Metabolomic Signatures of Hirschsprung's Disease Based on GC-MS and LC-MS.

  2023cites this paper
• Personalized Medicine in Medullary Thyroid Carcinoma: A Broad Review of Emerging Treatments

  2023cites this paper
• TAZ enhances mammary cell proliferation in 3D culture through transcriptional regulation of IRS1.

  2018cites this paper
• The role of the ShcD and RET interaction in neuroblastoma survival and migration

  2018cites this paper
• Exon Skipping in the RET Gene Encodes Novel Isoforms That Differentially Regulate RET Protein Signal Transduction*

  2016cites this paper
• PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy

  2015cites this paper
• The RET oncogene in papillary thyroid carcinoma

  2015cites this paper
• FOR DOCTORAL DEGREE ( Ph . D . )

  2015influential citation
• The Novel Functions of High-Molecular-Mass Complexes Containing Insulin Receptor Substrates in Mediation and Modulation of Insulin-Like Activities: Emerging Concept of Diverse Functions by IRS-Associated Proteins

  2015cites this paper
• RET Dependent Transcriptional Changes of Cell Signaling Proteins in Neuroblastoma Cells

  2015cites this paper
• Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease

  2015cites this paper
• Central role of RET in thyroid cancer.

  2013cites this paper
• Carlomagno Central Role of RET in Thyroid Cancer Subject Collection Signaling by Receptor Tyrosine Kinases CSF-1 Receptor Signaling in Myeloid Cells

  2013cites this paper
• Thyroid Cancer: Role of RET and Beyond

  2012cites this paper
• Superoxide dismutase 3-mediated cell survival and proliferation

  2012cites this paper
• Human Cancer Biology Activationof themTORPathway inPrimaryMedullary Thyroid Carcinoma and Lymph Node Metastases

  2012cites this paper
• RET: A Multi-Faceted Gene in Human Cancer

  2012cites this paper
• Functions of GDNF/Ret signaling in models of autosomal recessive Parkinson’s disease

  2012cites this paper
• Activation of the mTOR Pathway in Primary Medullary Thyroid Carcinoma and Lymph Node Metastases

  2012cites this paper
• Inhibition of RET activated pathways: novel strategies for therapeutic intervention in human cancers.

  2012cites this paper
• Orthovanadate-induced cell death in RET/PTC1-harboring cancer cells involves the activation of caspases and altered signaling through PI3K/Akt/mTOR.

  2011cites this paper
• Contribution of PKB/AKT signaling to thyroid cancer.

  2011cites this paper
• The RET receptor tyrosine kinase: mechanism, signaling and therapeutics

  2010cites this paper
• Functional and genetic studies in MEN2 and Hirschsprung disease

  2010cites this paper
• Control of neuronal survival, migration and outgrowth by GDNF and its receptors

  2010cites this paper
• XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway

  2009cites this paper
• Structure-Function Studies of GDNF Family Ligand-RET signalling

  2009cites this paper
• Neurotrophic factors in peripheral nervous system development : Function and specificity

  2008cites this paper
• INVESTIGATING THE RELATIONSHIP BETWEEN THE RET RECEPTOR, CBL, AND ARHGEF7 IN DOWNREGULATION OF RET

  2008cites this paper
• A phosphorylation-dependent gating mechanism controls the SH2 domain interactions of the Shc adaptor protein.

  2008cites this paper
• Deciphering adaptor specificity in GFL‐dependent RET‐mediated proliferation and neurite outgrowth

  2007cites this paper
• The Shc-binding site of the betac subunit of the GM-CSF/IL-3/IL-5 receptors is a negative regulator of hematopoiesis.

  2007cites this paper
• Oncogenic Transformation by the Signaling Adaptor Proteins Insulin Receptor Substrate (IRS)-1 and IRS-2

  2007cites this paper
• Screening for PTB Domain Binding Partners and Ligand Specificity Using Proteome-Derived NPXY Peptide Arrays

  2007cites this paper
• Doctorate Program in Molecular Oncology and Endocrinology

  2006cites this paper
• Engineering the Recruitment of Phosphotyrosine Binding Domain-containing Adaptor Proteins Reveals Distinct Roles for RET Receptor-mediated Cell Survival*

  2006cites this paper
• GDNF and Related Proteins

  2006cites this paper
• Mammary Tumorigenesis and Metastasis Caused by Overexpression of Insulin Receptor Substrate 1 (IRS-1) or IRS-2

  2006cites this paper
• RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors.

  2006cites this paper
• Structure and function of GDNF receptor alpha splice variants

  2006cites this paper
• Screening for PTB Domain Binding Partners and Ligand Specificity Using Proteome-Derived NPXY Peptide Arrays (cid:1) †

  2006cites this paper
• Screening for PTB Domain Binding Partners and LigandSpecificity Using Proteome-Derived NPXY Peptide Arrays

  2006cites this paper
• Differential effects of glial cell line‐derived neurotrophic factor and neurturin in RET/GFRα1‐expressing cells

  2006cites this paper
• Interaction of SH2-Bβ with RET is involved in signaling of GDNF-induced neurite outgrowth

  2006cites this paper
• 23. RET ACTIVATION IN MEDULLARY CARCINOMAS

  2005cites this paper
• MOLECULAR CHARACTERISATION OF RET TYROSINE KINASE SIGNALLING

  2005influential citation
• RET tyrosine kinase signaling in development and cancer.

  2005cites this paper
• RET activation in medullary carcinomas.

  2004cites this paper
• Enhancement of Tyrosine Hydroxylase Phosphorylation and Activity by Glial Cell Line-derived Neurotrophic Factor*

  2004cites this paper
• Biochemical and biological responses induced by coupling of Gab1 to phosphatidylinositol 3-kinase in RET-expressing cells.

  2004cites this paper
• A Targeting Mutation of Tyrosine 1062 in Ret Causes a Marked Decrease of Enteric Neurons and Renal Hypoplasia

  2004cites this paper
• Tyrosine 981, a Novel Ret Autophosphorylation Site, Binds c-Src to Mediate Neuronal Survival*

  2004cites this paper
• Dok-6, a Novel p62 Dok Family Member, Promotes Ret-mediated Neurite Outgrowth*

  2004cites this paper
• Dysfunction of the RET receptor in human cancer.

  2004cites this paper
• Differential requirement of Tyr1062 multidocking site by RET isoforms to promote neural cell scattering and epithelial cell branching

  2004cites this paper
• The RET Receptor Is Linked to Stress Response Pathways

  2004cites this paper
• Oncogenic protein tyrosine kinases

  2004cites this paper
• Structural Basis for the Specific Recognition of RET by the Dok1 Phosphotyrosine Binding Domain*

  2004cites this paper
• GDNF and insulin cooperate to enhance the proliferation and differentiation of enteric crest-derived cells.

  2003cites this paper
• Cell signalling and gene expression mediated by RET tyrosine kinase

  2003cites this paper
• Study of the ret receptor dysfunctions caused by mutations associated with human neoplastic disorders and developmental diseases.

  2003cites this paper
• Protein kinase Cα activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase

  2003influential citation
• RET and NTRK1 proto‐oncogenes in human diseases

  2003cites this paper
• Gentherapeutische Intervention beim medullären Schilddrüsenkarzinom durch adenoviral vermittelte Expression dominant-negativer RET Proto-Onkogen Mutanten

  2003influential citation
• The Glial Cell – Derived Neurotrophic Factor Signaling Pathway 35 Signaling Pathways of Glial Cell – Derived Neurotrophic Factor

  2003influential citation
• Shc and CEACAM1 Interact to Regulate the Mitogenic Action of Insulin*

  2002cites this paper
• Activation of RET tyrosine kinase regulates interleukin-8 production by multiple signaling pathways.

  2002cites this paper
• Conservation of RET proto-oncogene splicing variants and implications for RET isoform function

  2002influential citation
• The Neuron-Specific Rai (ShcC) Adaptor Protein Inhibits Apoptosis by Coupling Ret to the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway

  2002cites this paper
• The Long and Short Isoforms of Ret Function as Independent Signaling Complexes*

  2002cites this paper
• Signaling Pathway to the Phosphatidylinositol 3-Kinase / Akt Protein Inhibits Apoptosis by Coupling Ret ) Adaptor ShcC ( Rai The Neuron-Specific

  2002cites this paper
• Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications.

  2002cites this paper
• Ureteric bud outgrowth in response to RET activation is mediated by phosphatidylinositol 3-kinase.

  2002cites this paper
• Novel Mechanism of Regulation of Rac Activity and Lamellipodia Formation by RET Tyrosine Kinase*

  2002cites this paper
• Role of Dok1 in Cell Signaling Mediated by RET Tyrosine Kinase*

  2002cites this paper
• The effects of phosphorylation on adaptor protein function.

  2002cites this paper
• Differential interaction of Enigma protein with the two RET isoforms.

  2002cites this paper
• The RET receptor: function in development and dysfunction in congenital malformation.

  2001cites this paper
• RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho

  2001influential citation